lobbying_filings_raw: dca42b48-ebd6-41c5-8233-bcdf01cb0d4e
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| dca42b48-ebd6-41c5-8233-bcdf01cb0d4e | Q3 | 7758 | CALIFORNIA LIFE SCIENCES | 110904 | CALIFORNIA LIFE SCIENCES | 2012 | third_quarter | 2012-10-08T19:56:20.350000-04:00 | 160000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/dca42b48-ebd6-41c5-8233-bcdf01cb0d4e/", "filing_uuid": "dca42b48-ebd6-41c5-8233-bcdf01cb0d4e", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2012, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/dca42b48-ebd6-41c5-8233-bcdf01cb0d4e/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "160000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Holly Frisque, Sr. Director of Operations", "dt_posted": "2012-10-08T19:56:20.350000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "888 PROSPECT STREET, #220", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "LA JOLLA", "registrant_state": "CA", "registrant_zip": "92037", "registrant": {"id": 7758, "url": "https://lda.senate.gov/api/v1/registrants/7758/", "house_registrant_id": 33793, "name": "CALIFORNIA LIFE SCIENCES", "description": null, "address_1": "4242 Campus Point Court", "address_2": "Suite 110", "address_3": null, "address_4": null, "city": "San Diego", "state": "CA", "state_display": "California", "zip": "92121", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "JAYNE MCNICOL", "contact_telephone": "+1 650-871-3270", "dt_updated": "2026-01-19T17:24:30.729442-05:00"}, "client": {"id": 110904, "url": "https://lda.senate.gov/api/v1/clients/110904/", "client_id": 12, "name": "CALIFORNIA LIFE SCIENCES", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "1996-02-14"}, "lobbying_activities": [{"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "Support repeal of medical device tax. Support extension of R&D tax credit.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 39820, "prefix": "mr", "prefix_display": "MR.", "first_name": "TODD", "nickname": null, "middle_name": "E", "last_name": "GILLENWATER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Address concerns regarding uncertainty and unpredictability of FDA drug and device regulatory environment. Address concerns with Medicare Independent Payment Advisory Board (IPAB).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 39820, "prefix": "mr", "prefix_display": "MR.", "first_name": "TODD", "nickname": null, "middle_name": "E", "last_name": "GILLENWATER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Address concerns with Medicare Independent Payment Advisory Board (IPAB).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 39820, "prefix": "mr", "prefix_display": "MR.", "first_name": "TODD", "nickname": null, "middle_name": "E", "last_name": "GILLENWATER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpilefunding and preparation; FDA Appropriations. Support protection of US law regarding biosimilars (12 years data exclusivity).", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 39820, "prefix": "mr", "prefix_display": "MR.", "first_name": "TODD", "nickname": null, "middle_name": "E", "last_name": "GILLENWATER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |